Sebastien Le Roux | VP, Global Market Access & Healthcare Solutions
Glaxo Smith Kline Inc

Sebastien Le Roux, VP, Global Market Access & Healthcare Solutions, Glaxo Smith Kline Inc

Sebastien Le Roux, currently VP, Global Market Access at GSK. Sebastien is a trained Pharmacist and has a Master Degree in Pharmaceutical industry from ESCP-EAP Business school in Paris.
Sebastien has 20+ more years of experience in the pharmaceutical sector and held various commercial positions before taking his current role. Most recently, Sebastien was Head of Selling Excellence for Europe, Paediatric Vaccines Business Unit Head, VP Commercial Director for Specialty in France, before moving to Canada as General Manager for ViiV Healthcare.
Sebastien is French National from Marseille in the South of France.


Day One World Pharma Pricing & Market Access EU Congress @ 11:25

Market access and commercial developments for immuno-oncology products

  • Rate of IO trial initiation has doubled in the past 12 months with more than 50 new trials now starting each month. And in spite of recent unfavourable trial results, three quarters of the respondents of a beacon intelligence survey predicted this rate of growth will be sustained.
  • Rapid evolution of the IO market requires close coordination and alignment between Key stakeholders
  • How to balance economic pressures, value for patients and the industry 

back to speakers